Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

IBRX

ImmunityBio, Inc.

CIK 0001326110 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$7.79
↓ 0.05 (-0.64%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership, Technicals, Options

Key stats

Market Cap
$8.26B
P/E Ratio
-8.32
EPS
-0.38
Dividend Yield
Not covered
52W Position
56%
Beta
1.56

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-7.89
P/S
49.80
EV/Revenue
49.34
ROE
94.9%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 56%
$1.95$12.43

Latest Financials

2025-12-31 FY
Revenue
$113.29M
Net Income
-$351.40M
Total Assets
$501.90M
Free Cash Flow
-$308.78M

Recent news